The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan-Reference-Cited by-同舟云学术

The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan

Published:2016-05 Issue: Volume:107 Page:102-110
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Arifa Raquel Duque Nascimento,Paula Talles Prosperi de,Madeira Mila Fernandes Moreira,Lima Renata Lacerda,Garcia Zélia Menezes,ÿvila Thiago Vinícius,Pinho Vanessa,Barcelos Lucíola Silva,Pinheiro Maurício Veloso Brant,Ladeira Luiz Orlando,Krambrock Klaus,Teixeira Mauro Martins,Souza Danielle Glória

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Publisher

Elsevier BV

Subject

Pharmacology

Reference67 articles.

1. Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level;Boige;Eur. J. Cancer,2006

2. First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer;Park;Oncology,2004

3. First-line treatment with capecitabine combined with irinotecan in patients with advanced colorectal carcinoma: a phase II study;Assy;J. Clin. Gastroenterol.,2012

4. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage;Bowen;Anticancer Drugs,2007

5. Irinotecan as a second-line monotherapy for small cell lung cancer;Sevinc;Asian Pac. J. Cancer Prev.,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RIP3 regulates doxorubicin-induced intestinal mucositis via FUT2-mediated α-1,2-fucosylation;Inflammation Research;2024-08-24

2. Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro;Toxicology in Vitro;2024-08

3. Irinotecan cause the side effects on development and adult physiology, and induces intestinal damage via innate immune response and oxidative damage in Drosophila;Biomedicine & Pharmacotherapy;2023-12

4. Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice;Biochemical Pharmacology;2023-10

5. Rodent models for anticancer toxicity studies: Contributions to drug development and future perspectives;Drug Discovery Today;2023-07